HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leitman, D. C. Articles by Murad, F. Search for Related Content PubMed PubMed Citation Articles by Leitman, D. C. Articles by Murad, F. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 261, Issue 25, 11650-11655, 09, 1986

Identification of multiple binding sites for atrial natriuretic factor by affinity cross-linking in cultured endothelial cells

DC Leitman, JW Andresen, T Kuno, Y Kamisaki, JK Chang and F Murad

In a previous study, we found that atriopeptin I was much weaker (EC50 greater than 500 nM) than atrial natriuretic factor (ANF-(8-33)) (EC50 = 0.3 nM) at increasing cyclic GMP in cultured endothelial cells. In this study, we used the cross-linking reagent disuccinimidyl suberate to investigate whether the differences in activity were due to the presence of multiple ANF receptors. When 98% of the ANF-binding sites on endothelial cells were occupied by tyrosine-atriopeptin I after cross-linking, there was no difference in the concentration-response curve to ANF-(8-33) with regard to cyclic GMP accumulation. In contrast, when 96% of the binding sites were occupied by cross-linked ANF-(8-33), a 60% decrease in the maximal cyclic GMP response was observed after the readdition of ANF-(8-33). These results suggest that ANF-(8-33) is binding to an additional site that atriopeptin I does not effectively bind. Affinity cross-linking of 125I-ANF to intact endothelial cells resulted in the labeling of two sites of Mr approximately 66,000 and approximately 130,000. Approximately 94% of the 125I-ANF binding sites had an Mr approximately 66,000. Labeling of this site was inhibited by both tyrosine-atriopeptin I (KI = 0.9 nM) and ANF-(8-33) (KI = 0.09 nM). Although 0.1 microM tyrosine-atriopeptin (AP I) inhibited labeling of the 66,000-dalton site to nearly the same degree as ANF-(8-33), it produced only a 4-fold increase in cyclic GMP compared to a 400-fold increase with ANF-(8-33). These results suggest that the 66,000-dalton site is not coupled to guanylate cyclase and cyclic GMP formation. Tyrosine-AP I (KI greater than 10 nM) was much weaker at competing for the 130,000-dalton site than ANF-(8-33) (KI = 0.075 nM). Because the EC50 for cyclic GMP stimulation for tyrosine-AP I (greater than 100 nM) and ANF-(8-33) (0.4 nM) is closer to the KI values for the 130,000-dalton protein, this site probably mediates the marked stimulation of cyclic GMP. Our results demonstrate that endothelial cells contain two binding sites for ANF-(8-33) and suggest that only the less abundant site (Mr approximately 130,000) is the receptor coupled to the activation of guanylate cyclase.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Schreier, S. Borner, K. Volker, S. Gambaryan, S. C. Schafer, P. Kuhlencordt, B. Gassner, and M. Kuhn The Heart Communicates with the Endothelium through the Guanylyl Cyclase-A Receptor: Acute Handling of Intravascular Volume in Response to Volume Expansion Endocrinology, August 1, 2008; 149(8): 4193 - 4199. [Abstract] [Full Text] [PDF]

				K. Sabrane, S. Gambaryan, R. P. Brandes, R. Holtwick, M. Voss, and M. Kuhn Increased Sensitivity to Endothelial Nitric Oxide (NO) Contributes to Arterial Normotension in Mice with Vascular Smooth Muscle-selective Deletion of the Atrial Natriuretic Peptide (ANP) Receptor J. Biol. Chem., May 9, 2003; 278(20): 17963 - 17968. [Abstract] [Full Text] [PDF]

				F. Brunner and G. Wolkart Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature Cardiovasc Res, August 15, 2001; 51(3): 577 - 584. [Abstract] [Full Text] [PDF]

				L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF]

				L. G. Melo, A. T. Veress, U. Ackermann, and H. Sonnenberg Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1826 - H1833. [Abstract] [Full Text] [PDF]

				K. Fujishige, N. Yanaka, H. Akatsuka, and K. Omori Localization of clearance receptor in rat lung and trachea: association with chondrogenic differentiation Am J Physiol Lung Cell Mol Physiol, March 1, 1998; 274(3): L425 - L431. [Abstract] [Full Text] [PDF]

				J.-P. Valentin, W.-Z. Ying, W. G. Couser, and M. H. Humphreys Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome Am J Physiol Renal Physiol, March 1, 1998; 274(3): F556 - F563. [Abstract] [Full Text] [PDF]

				D. W. Zlock, L. Cao, J. Wu, and D. G. Gardner Thrombin Inhibits Atrial Natriuretic Peptide Receptor Activity in Cultured Bovine Endothelial Cells Hypertension, January 1, 1997; 29(1): 83 - 90. [Abstract] [Full Text]

				T. Abe, Y. Arakawa, A. K. Rajasekaran, T.-H. Yu, and O. Wada Interaction of Atrial Natriuretic Peptide with Its Receptors in Bovine Lung Membranes J. Biol. Chem., March 31, 1995; 270(13): 7672 - 7678. [Abstract] [Full Text] [PDF]

				F. Murad, D. Leitman, S. Waldman, C.-H. Chang, M. Hirata, and K. Kohse Effects of Nitrovasodilators, Endothelium-dependent Vasodilators, and Atrial Peptides on cGMP Cold Spring Harb Symp Quant Biol, January 1, 1988; 53(0): 1005 - 1009. [Abstract] [PDF]